Ctx Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 31.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 4.45 Cr
as on 16-11-2024
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 36.50 Cr
as on 16-11-2024
- Satisfied Charges ₹ 20.50 Cr
as on 16-11-2024
- Revenue 15.88%
(FY 2023)
- Profit -42.33%
(FY 2023)
- Ebitda -51.29%
(FY 2023)
- Net Worth 10.04%
(FY 2023)
- Total Assets 5.67%
(FY 2023)
About Ctx Lifesciences
The Corporate was formerly known as Ctx Pharmaceuticals And Chemicals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 31.50 Cr and a paid-up capital of Rs 4.45 Cr.
The company currently has active open charges totaling ₹36.50 Cr. The company has closed loans amounting to ₹20.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pravinchandra Kabutarwala, Bipinchandra Kabutarwala, Jayantilal Jariwala, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24114GJ2004PTC043554
- Company No.
043554
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationSurat, Gujarat
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ctx Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayantilal Jariwala  | Managing Director | 02-Mar-2011 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pravinchandra Kabutarwala | Director | 05-Feb-2004 | Current |
| Bipinchandra Kabutarwala | Director | 05-Feb-2004 | Current |
| Vishadkumar Jariwala | Director | 05-Feb-2004 | Current |
| Kanakkumar Jariwala | Director | 05-Feb-2004 | Current |
Financial Performance of Ctx Lifesciences.
Ctx Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.88% increase. The company also saw a substantial fall in profitability, with a 42.33% decrease in profit. The company's net worth Soared by an impressive increase of 10.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ctx Lifesciences?
In 2023, Ctx Lifesciences had a promoter holding of 98.12% and a public holding of 1.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Colourtex Industries Private LimitedActive 35 years 2 monthsPravinchandra Kabutarwala, Jayantilal Jariwala and 2 more are mutual person
- Vijay Foundry And Machine Works Pvt LtdActive 50 years 2 months
Pravinchandra Kabutarwala, Bipinchandra Kabutarwala and 2 more are mutual person
Coconut Softwares Private LimitedActive 24 years 9 monthsPravinchandra Kabutarwala, Bipinchandra Kabutarwala and 2 more are mutual person
Jenil Enterprise Private LimitedActive 10 years 1 monthBipinchandra Kabutarwala, Jayantilal Jariwala and 2 more are mutual person
- Dahej Eco Care Private LimitedActive 9 years 7 days
Bipinchandra Kabutarwala, Jayantilal Jariwala and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 13 Apr 2010 | ₹36.50 Cr | Open |
Idbi Bank Limited Creation Date: 04 Feb 2015 | ₹9.50 Cr | Satisfied |
Bank Of Baroda Creation Date: 13 Jul 2006 | ₹11.00 Cr | Satisfied |
How Many Employees Work at Ctx Lifesciences?
Ctx Lifesciences has a workforce of 636 employees as of Oct 13, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ctx Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ctx Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
